StoneX Group’s Mangoceuticals MGRX Stock Holding History

StoneX Group’s Portfolio MGRX Stock Details MGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-16,039	Closed	-$5.78K	–	1528
2026 Q1	$5.78K	Buy	+16,039	New	+$7.68K	﹤0.01%	877
2024 Q4	–	Sell	-910	Closed	-$3.22K	–	910
2024 Q3	$3.22K	Buy	+910	New	+$4.29K	﹤0.01%	646

Other funds holding MGRX

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

ACA

Ackerman Capital Advisors Dallas, Texas $497M AUM 16.31% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

StoneX Group's MGRX Position: Q2 2026 in Review

StoneX Group sold out of Mangoceuticals (MGRX) in Q2 2026, closing a stake of 16,039 shares — an estimated $5.78K sold.

StoneX Group first reported a position in MGRX in Q3 2024 and held it in 2 quarters. The position peaked at $5.78K in Q1 2026. 18 funds tracked by Wall St. Rank hold MGRX as of Q2 2026.

StoneX Group reported no remaining Mangoceuticals position as of Q2 2026 after selling out during the quarter.
StoneX Group sold 16,039 Mangoceuticals shares in Q2 2026, an estimated $5.78K.
StoneX Group first reported a position in Mangoceuticals in Q3 2024 and held it in 2 quarters.
StoneX Group's Mangoceuticals position peaked at $5.78K in Q1 2026.
18 funds tracked by Wall St. Rank held Mangoceuticals as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.